{"transactions":[{"id":1974563,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":116039,"kind":"person","name":"Hazeltine Mark","position":1,"cik":"0001852986","reported_name":"Hazeltine Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-03-03T16:37:31.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":3667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2021."}],"balance_after":190205,"source":{"system":"sec-edgar","filing":"0001274737-23-000013","document":"wf-form4_167787940835174.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852986/000127473723000013/wf-form4_167787940835174.xml","form_type":"4"}},{"id":1983961,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":116039,"kind":"person","name":"Hazeltine Mark","position":1,"cik":"0001852986","reported_name":"Hazeltine Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-03-01T16:06:12.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 100,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of March 1, 2023, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in accordance with the Company's Amended and Restated Executive Change in Control Severance Plan, as the same may be amended from time to time."}],"balance_after":193872,"source":{"system":"sec-edgar","filing":"0001274737-23-000011","document":"wf-form4_167770470514707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852986/000127473723000011/wf-form4_167770470514707.xml","form_type":"4"}},{"id":2022926,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":116039,"kind":"person","name":"Hazeltine Mark","position":1,"cik":"0001852986","reported_name":"Hazeltine Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-02-10T16:08:38.000Z","date":"2023-02-08","kind":"sale","acquired":false,"shares":5821,"price":2.6924,"value":15672.4604,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 4, 2022."}],"balance_after":93872,"source":{"system":"sec-edgar","filing":"0001274737-23-000008","document":"wf-form4_167606330014830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852986/000127473723000008/wf-form4_167606330014830.xml","form_type":"4"}},{"id":2361292,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":116039,"kind":"person","name":"Hazeltine Mark","position":1,"cik":"0001852986","reported_name":"Hazeltine Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-03-02T16:40:07.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":3241,"price":7.12,"value":23075.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the Reporting Person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted on February 23, 2021."}],"balance_after":99693,"source":{"system":"sec-edgar","filing":"0001274737-22-000018","document":"wf-form4_164625718287172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852986/000127473722000018/wf-form4_164625718287172.xml","form_type":"4"}},{"id":2408618,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":116039,"kind":"person","name":"Hazeltine Mark","position":1,"cik":"0001852986","reported_name":"Hazeltine Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-02-08T16:21:48.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":63500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 63,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of February 4, 2022, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 63,500 shares of restricted stock units granted on February 4, 2022, 37,500 shares of restricted stock units granted on February 23, 2021 and 1,934 shares of common stock."}],"balance_after":102934,"source":{"system":"sec-edgar","filing":"0001274737-22-000010","document":"wf-form4_164435529026997.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852986/000127473722000010/wf-form4_164435529026997.xml","form_type":"4"}},{"id":2710542,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":116039,"kind":"person","name":"Hazeltine Mark","position":1,"cik":"0001852986","reported_name":"Hazeltine Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option(right to buy)","published_at":"2021-05-17T20:06:20.000Z","date":"2021-05-17","kind":"exercise","acquired":false,"shares":1934,"price":0.26,"value":502.84,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable as it vests. 25% of the shares subject to the option vested on October 5, 2019, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":1061,"derivative":{"exercise_price":0.26,"expiration_date":"2028-10-05","underlying":"Common Stock","underlying_shares":2995},"source":{"system":"sec-edgar","filing":"0001274737-21-000047","document":"wf-form4_162129636235638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852986/000127473721000047/wf-form4_162129636235638.xml","form_type":"4"}},{"id":2710541,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":116039,"kind":"person","name":"Hazeltine Mark","position":1,"cik":"0001852986","reported_name":"Hazeltine Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-05-17T20:06:20.000Z","date":"2021-05-17","kind":"exercise","acquired":true,"shares":1934,"price":0.26,"value":502.84,"ownership":{"direct":true},"balance_after":39434,"source":{"system":"sec-edgar","filing":"0001274737-21-000047","document":"wf-form4_162129636235638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852986/000127473721000047/wf-form4_162129636235638.xml","form_type":"4"}}]}